<DOC>
	<DOCNO>NCT01770600</DOCNO>
	<brief_summary>This study dedicate achieve well understand brain process information . Specifically , investigator study cognitive function , think process , impulsivity people without suicidal thought . You ask participate research study learn use medication , risperidone , improve symptom depression . Specifically investigator study effectiveness reduce think suicide symptom severe depression . Risperidone approve FDA treatment schizophrenia bipolar mania , clinical practice suggests might benefit patient major depressive disorder . During clinical trial 2607 patient , risperidone prove safe . This pilot study test new indication risperidone treatment severe depression . The study medication give addition usual psychiatric care .</brief_summary>
	<brief_title>Impulsivity Thought Process Disorder Patients With Active Suicidal Ideation Depression</brief_title>
	<detailed_description>Men woman age 19-64 , diagnosis major depressive disorder , currently severe depressive episode suicidal thought , eligible participate voluntary research study . A control group consist men woman age 19-64 diagnosis major depressive disorder currently severe depressive episode suicidal thought . During screen visit , appropriate demographic , medical , psychiatric data collect , include diagnostic assessment assessment severity depression . You ask complete several pen pencil questionnaire learn current state mind . This evaluation take approximately two hour . If qualify control assessment group , ask meet researcher 2 , 4 6 day initial evaluation . If qualify study group , randomly ( like flip coin ) assign computer receive either risperidone ( 1-2 mg/day ) placebo day mouth . You take study medication 5 night addition standard care antidepressant prescribe doctor . Forty participant enter double-blind study , mean neither doctor know study medicine ( risperidone placebo ) receiving . If medically necessary , medication information release doctor find medicine randomly assign . You follow-up evaluation ( either hospital returning office visit ) Day 5 . At visit , evaluate psychiatrist ask complete questionnaire design assess effect study medication symptom . At visit also ask possible side effect tolerate medicine . These visit take approximately one hour . At screen end five day treatment , additional neuropsychological evaluation administer assess progress . These additional assessment take approximately one hour complete . Members control group receive study related medication return follow visit . Information Women Childbearing Potential Men Fathering Child Because risperidone may affect mother 's milk develop fetus , breast-feeding pregnant woman allow take part study . Women become pregnant must take pregnancy test start study . Unless child surgery medical reason , men woman must use effective method birth control start study . Effective birth control include birth control pill , patch , IUD , condom , sponge , diaphragm spermicide , avoid sexual activity could cause pregnancy . Optional functional MRI ( fMRI ) brain Sub-study 10 participant participate fMRI sub-study , include 5 day open-label trial risperidone . An fMRI scan do prior receive study drug 5 day later . During fMRI , picture brain obtain . The fMRI procedure require lie still narrow table circular scanner around head . The fMRI scan take approximately 40 minute . Two neuropsychological assessment administer scan . Sub-study participant complete computer-based version task perform fMRI scan prior brain imaging session . This necessary ensure understand task perform image take place . Electing participate sub-study jeopardize participation drug trial . A neurologist , Dr. Lawrence Ver Hoef review MRI scan incidental finding .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Age : 1964 Suicidality score &gt; 4 MontgomeryAsberg Depression Rating Scale ( MADRS ) pregnant , medically unstable , history schizophrenia , schizoaffective disorder , bipolar disorder , psychosis NOS , urine drug screen positive cocaine , marijuana amphetamine , withdrawal opiate , benzodiazepine alcohol , currently antipsychotic drug therapy . Also excluded subject require use mood stabilizer antipsychotic .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Age 19 64</keyword>
	<keyword>Medically stable</keyword>
	<keyword>No current history psychosis</keyword>
	<keyword>No alcohol benzodiazepine withdrawal</keyword>
</DOC>